Table 2 Summary of QoL survey results by % of area of involvement in vitiligo participants
Patient/parent grouping (area of involvement) | N (%) for each survey (FLDQI and QLCCDQ) | Mean FDLQI overall score ± SD | Mean QLCCDQ per-item score ± SD | Mean QLCCDQ social domain score ± SD | Mean QLCCDQ occupational roles domain score ± SD | Mean QLCCDQ symptom domain score ± SD | Mean QLCCDQ emotional roles domain ± SD score | Mean QLCCDQ family perception domain score ± SD |
|---|---|---|---|---|---|---|---|---|
0–25% | 78 (66.1%, FLDQI); 77 (65.3%, QLCCDQ) | 12.3 ± 2.7 | 6.1 ± 1.2 | 6.7 ± 1.2 | 6.5 ± 1.2 | 6.0 ± 1.5 | 5.4 ± 1.5 | 6.6 ± 1.2 |
25–50% | 26 (22.0% FLDQI; 22.2% QLCCDQ) | 14.0 ± 4.3 | 5.7 ± 1.2 | 6.6 ± 1.1 | 6.3 ± 1.5 | 5.0 ± 1.4 | 4.8 ± 1.6 | 6.7 ± 1.1 |
50–75% | 8 (6.8% for both FLDQI and QLCCDQ) | 15.3 ± 3.5 | 5.7 ± 0.7 | 6.9 ± 0.3 | 6.7 ± 0.4 | 4.7 ± 1.6 | 4.1 ± 2.0 | 6.9 ± 0.2 |
75–100% | 6 (5.1% for both FLDQI and QLCCDQ) | 15.8 ± 6.5 | 5.3 ± 1.0 | 6.4 ± 1.0 | 5.7 ± 1.7 | 4.7 ± 1.4 | 4.2 ± 1.1 | 6.3 ± 1.1 |
Overall | 118 (FLDQI); 117 (QLCCDQ) | 13.1 ± 3.5 | 5.9 ± 1.1 | 6.6 ± 1.3 | 6.4 ± 1.5 | 5.6 ± 1.6 | 5.1 ± 1.6 | 6.6 ± 1.1 |